Ravi Prakash Sahu
Overview
Explore the profile of Ravi Prakash Sahu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Althaiban A, Thyagarajan A, Sahu R
Mini Rev Med Chem
. 2022 Dec;
23(8):953-961.
PMID: 36573057
Pancreatic ductal adenocarcinoma (PDAC) is one of the highly aggressive malignancies and the leading cause of cancer-related deaths. Despite recent advancements, the overall therapeutic responses in PDAC patients remained relatively...
2.
Abhilasha K, Sumanth M, Thyagarajan A, Sahu R, Kemparaju K, Marathe G
Platelets
. 2020 Aug;
32(7):960-967.
PMID: 32835559
Bacterial toxins signaling through Toll-like receptors (TLRs) are implicated in the pathogenesis of many inflammatory diseases. Among the toxins, lipopolysaccharide (LPS) exerts its action via TLR-4 while lipoteichoic acid (LTA)...
3.
Abhilasha K, Sumanth M, Chaithra V, Jacob S, Thyagarajan A, Sahu R, et al.
Free Radic Biol Med
. 2019 Aug;
143:275-287.
PMID: 31442556
Platelet-activating factor (PAF) is a potent inflammatory agonist. In Swiss albino mice, intraperitoneal injection of PAF causes sudden death with oxidative stress and disseminated intravascular coagulation (DIC), characterized by prolonged...
4.
Thyagarajan A, Shaban A, Sahu R
J Pharmacol Exp Ther
. 2017 Oct;
364(1):1-12.
PMID: 29054858
Acquired tumor resistance to cancer therapies poses major challenges in the treatment of cancers including melanoma. Among several signaling pathways or factors that affect neocarcinogenesis, cancer progression, and therapies, altered...
5.
Sahu R
Mol Med Rep
. 2015 Feb;
12(1):394-400.
PMID: 25695262
Melanoma cells often express platelet-activating factor receptor (PAF-R), which has been demonstrated to increase metastatic behavior. However, the effect of PAF-R on the responsiveness of melanoma to naturally occurring cytotoxic...
6.
Sahu R, Epperly M, Srivastava S
Front Biosci (Elite Ed)
. 2009 Jun;
1(2):568-76.
PMID: 19482673
Increase in systemic toxicity and resistance are the major drawbacks of radiation therapy in the treatment of pancreatic cancer. We have shown previously that BITC inhibits the growth of human...